Source: Eur Respir Rev, 26 (146) 170066; 10.1183/16000617.0066-2017



Rating:

Share or cite this content

Citations should be made in the following way:
Céline Mascaux, Pascale Tomasini, Laurent Greillier, Fabrice Barlesi. Personalised medicine for nonsmall cell lung cancer. Eur Respir Rev, 26 (146) 170066; 10.1183/16000617.0066-2017

Member's Comments

No comment yet.

Related content which might interest you: Update on nonsmall cell lung cancer Source: Eur Respir Rev 2010 19: 173-185 Year: 2010 Biological therapies in nonsmall cell lung cancer Source: Eur Respir J , 49 (3) 1601520; DOI: 10.1183/13993003.01520-2016 Year: 2017 New treatment options for nonsmall cell lung cancer and small cell lung cancer Source: Annual Congress 2006 - PG12 - Small cell lung cancer management Year: 2006 Radio(chemo)therapy in locally advanced nonsmall cell lung cancer Source: Eur Respir Rev 2015; 25: 65-70 Year: 2016 Targeted therapy in non-small cell lung cancer Source: Breathe 2012; 8: 206-215 Year: 2012 Anticancer treatment for advanced non-small cell lung cancer Source: Breathe 2011; 8: 124-133 Year: 2011 Combined radiotherapy for nonsmall cell lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 31s Year: 2003 Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives Source: Eur Respir Rev 2011; 20: 45-52 Year: 2011 Therapeutic options targeting angiogenesis in nonsmall cell lung cancer Source: Eur Respir Rev 2014; 23: 79-91 Year: 2014 Radiotherapy in the treatment of nonsmall cell lung cancer Source: Eur Respir Mon; 2009: 44: 207–243 Year: 2009 Advanced non-small cell lung cancer in elderly patients Source: Breathe 2012; 9: 26-34 Year: 2012 Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018 Interdisciplinary multimodality management of stage III nonsmall cell lung cancer Source: Eur Respir Rev, 28 (152) 190024; 10.1183/16000617.0024-2019 Year: 2019 Second line therapy for advanced non-small cell lung cancer Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 First- and second-line therapy for advanced nonsmall cell lung cancer Source: Eur Respir J 2009; 33: 915-930 Year: 2009 Bronchoscopic intratumoural therapies for non-small cell lung cancer Source: Eur Respir Rev, 29 (156) 200028; 10.1183/16000617.0028-2020 Year: 2020 Nonsmall cell lung cancer Source: Annual Congress 2012 - Maurizio Vignola Award for Innovation in Pneumology Ceremony (supported by Chiesi Foundation) followed by Clinical Year in Review I Year: 2012 Clinical features of nonsmall cell lung cancer cases Source: Eur Respir J 2002; 20: Suppl. 38, 75s Year: 2002